We are live on ! Find out more
CGIM

Cannon Global Investment Management Portfolio holdings

AUM $35.4M
1-Year Est. Return 47.4%
This Fund
S&P 500
This Quarter Est. Return
-0.45%
1 Year Est. Return
+47.4%
3 Year Est. Return
+136.48%
5 Year Est. Return
10 Year Est. Return
AUM
$57M
AUM Growth
+$10.9M
Cap. Flow
+$12M
Cap. Flow %
21.02%
Top 10 Hldgs %
56.07%
Holding
119
New
48
Increased
14
Reduced
15
Closed
41

Top Buys

Rank Stock Value
1
X
US Steel
X
+$1.86M
2
BAM icon
Brookfield Asset Management
BAM
+$1.42M
3
BAH icon
Booz Allen Hamilton
BAH
+$1.21M
4
APG icon
APi Group
APG
+$1.15M
5
SHOP icon
Shopify
SHOP
+$1.1M

Sector Composition

Rank Sector Weight
1 Financials 12.14%
2 Materials 7.91%
3 Healthcare 7.68%
4 Technology 7.28%
5 Energy 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FG icon
51
F&G Annuities & Life
FG
$3.48B
$270K 0.47%
+7,500
New +$315K
HRI icon
52
Herc Holdings
HRI
$5.63B
$269K 0.47%
2,000
+500
+33% +$85.2K
DNB
53
DELISTED
Dun & Bradstreet
DNB
$268K 0.47%
+30,000
New +$307K
CLMT icon
54
Calumet Specialty Products
CLMT
$4.15B
$252K 0.44%
+19,900
New +$313K
CYTK icon
55
Cytokinetics
CYTK
$10.5B
$241K 0.42%
+6,000
New +$276K
TRU icon
56
TransUnion
TRU
$15.2B
$241K 0.42%
+2,900
New +$265K
DCTH icon
57
Delcath Systems
DCTH
$594M
$239K 0.42%
+18,800
New +$267K
EXOD
58
Exodus Movement Inc
EXOD
$156M
$201K 0.35%
+4,400
New +$195K
HURN icon
59
Huron Consulting
HURN
$2.39B
$201K 0.35%
+1,400
New +$188K
ORKA
60
Oruka Therapeutics
ORKA
$7.11B
$195K 0.34%
+19,000
New +$237K
CLOV icon
61
Clover Health Investments
CLOV
$2.41B
$178K 0.31%
+49,500
New +$199K
TTAM
62
Titan America SA
TTAM
$2.96B
$160K 0.28%
+11,800
New +$174K
LFVN icon
63
LifeVantage
LFVN
$82.1M
$156K 0.27%
+10,700
New +$202K
ETON icon
64
Eton Pharmaceutcials
ETON
$1.14B
$148K 0.26%
+11,400
New +$172K
EBS icon
65
Emergent Biosolutions
EBS
$233M
$144K 0.25%
+29,600
New +$245K
ATYR
66
aTyr Pharma
ATYR
$53M
$143K 0.25%
+47,500
New +$173K
CLPT icon
67
ClearPoint Neuro
CLPT
$463M
$143K 0.25%
+12,000
New +$187K
EHTH icon
68
eHealth
EHTH
$39.7M
$121K 0.21%
+18,100
New +$165K
CRVS icon
69
Corvus Pharmaceuticals
CRVS
$1.27B
$111K 0.2%
+35,000
New +$165K
GSM icon
70
FerroAtlántica
GSM
$832M
$96.5K 0.17%
+26,000
New +$100K
INDV icon
71
Indivior Pharmaceuticals
INDV
$4.57B
$95.3K 0.17%
+10,000
New +$105K
AMLX icon
72
Amylyx Pharmaceuticals
AMLX
$2.6B
$90.3K 0.16%
+25,500
New +$90.7K
MDXG icon
73
MiMedx Group
MDXG
$624M
$76K 0.13%
10,000
-15,500
-61% -$130K
ABEO icon
74
Abeona Therapeutics
ABEO
$425M
$66.6K 0.12%
+14,000
New +$76.1K
GEVO icon
75
Gevo
GEVO
$391M
$58K 0.1%
+50,000
New +$83.7K

Similar funds

Cannon Global Investment Management's Q1 2025 Portfolio in Review

As of Q1 2025, Cannon Global Investment Management held 119 positions worth $57M, up 24% from $46.1M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Cannon Global Investment Management deployed $12M of net new capital in Q1 2025, opening 48 new positions and adding to 14 existing holdings. Its largest new stake was Brookfield Asset Management: 26,000 shares worth $1.26M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 12% a quarter earlier, followed by Materials and Healthcare.

On the sell side, the largest reduction was Discover Financial Services, an estimated $1.04M trimmed.

  • Cannon Global Investment Management's largest Q1 2025 buy was Brookfield Asset Management: 26,000 shares worth $1.26M.
  • Cannon Global Investment Management added most to US Steel in Q1 2025, an estimated $1.86M increase.
  • Cannon Global Investment Management's biggest Q1 2025 reduction was Discover Financial Services, cutting an estimated $1.04M.
  • Cannon Global Investment Management fully exited Acadia Pharmaceuticals in Q1 2025, selling an estimated $2.17M.
  • Cannon Global Investment Management's ten largest holdings make up 56% of its $57M portfolio in Q1 2025.
  • Cannon Global Investment Management opened 48 new positions and closed 41 in Q1 2025.
  • Cannon Global Investment Management's portfolio value rose 24% quarter-over-quarter to $57M.

Based on Cannon Global Investment Management's 13F filing for Q1 2025, filed 28 Apr 2025.